There are striking trends in the Small Animal Imaging Market that depict the changing face of preclinical research and diagnostics. With technological advancements transforming the industry, there has been a surge in demand for state-of-the-art imaging modalities customized for small animals. One of their latest trends is the increasing adoption of molecular imaging techniques such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT). These methods provide researchers with insights into disease progression and treatment response as they allow them to explore molecular or cellular processes within living organisms.
Another significant influence on developments in the Small Animal Imaging Market is toward multi-modal imaging systems. Research workers require hybrid systems that incorporate numerous imaging modalities like Magnetic Resonance Imaging (MRI), computed tomography (CT), optical imaging among others. This trend arises from the fact that complementary nature of different modes enables a more comprehensive understanding of biological processes at different levels which enhances availability of versatile, multi-functional instruments for use across most aspects of preclinical research.
In addition, another change occurring within the Small Animal Imaging Market has been noticed whereby 3D imaging technologies are coming into effect. Conventional 2D imaging techniques have seen augmentation or substitution by a range of three dimensional imaging modality providing an accurate representation of anatomical structures and pathological changes. This change is best shown in cases involving oncology where visualization requires precise detailing about tumor morphology and microenvironments to develop targeted therapies.
The development advanced contrast agents also contributes to this market’s growth rate. The latter enables typically invisible structures or specific molecular targets be seen clearly during image capturing exercises thus improving diagnostic accuracy in preclinical studies. Improved contrast agents are being sought because sensitivity and specificity need to be improved upon when it comes to application phase; facilitating deeper comprehension with regards to biological processes among small animals.
Moreover, automation together with artificial intelligence (AI) are becoming essential elements found within several small animal imaging systems. Automation makes imaging more efficient and reproducible in preclinical studies. On the other hand, AI-powered image analysis tools enable meaningful information to be extracted from complex imaging datasets quickly hence expediting the entire research workflow and allowing researchers to concentrate on interpretation and decision making.
Small Animal Imaging Market does not go through only technological advancements but also geographic expansions. Many markets are now focusing on developing economies as they realize diseases have become common and healthcare infrastructure needs to be improved upon. This will widen access to small animal imaging technologies, boost global cooperation in preclinical research as well as drug development.”
Small Animal Imaging Market size was valued at USD 1.12 billion in 2022. The small animal imaging market industry is projected to grow from USD 1.19 Billion in 2023 to USD 2.32 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.87% during the forecast period (2023 - 2032).
The increasing R&D investment by pharmaceutical industry and rising awareness of small animal research are driving market growth.
February 2024: IONETIX, a premier manufacturer of cyclotron technology and isotopes, is delighted to announce the commencement of our partnership with Provision Diagnostic Imaging in Knoxville. This partnership is based on the use of N-13 Ammonia, which is produced on-site by IONETIX.
Provision Diagnostic Imaging is a regional leader and pioneer in medical diagnostics, recognized for its innovative and advanced technology that is rooted in global technology development. It is a free-standing outpatient diagnostic center that is frequently the first to introduce this technology to patients and providers in the East Tennessee region.
Provision Diagnostic Imaging's dedication to collaborating with Ionetix to provide a Cardiac PET/CT program is an additional method of providing our community with cutting-edge technology that enables patients to receive more timely diagnoses and treatment options, which have a significant impact on most desired clinical outcomes.
Aoril 2023: Hallmarq Veterinary Imaging has introduced the world's first veterinary magnetic resonance imaging (MRI) system that does not utilize helium to chill its magnet coils. In order to obtain high-quality images, the coils must be chilled to -460 °F. The new MRI from Hallmarq employs a conduction-based cooling system in a strong vacuum to accomplish the same result without helium. This eliminates the necessity for helium, a quench pipe, an oxygen monitor, or any additional power.
According to Hallmarq, this renders the new system more environmentally favorable than its helium-based counterparts and decreases the initial and ongoing expenses associated with providing a veterinary MRI service to patients. The new technology is a response to the increasing apprehensions regarding the availability of helium.
Hallmarq reports that helium prices have increased from £12.75 per liter in December 2017 to between £50 and £55 per liter in June 2022 due to the rapid outpacing of its natural synthesis by extraction and utilization. It may not be sustainable for veterinary hospitals that are currently employing high-field MRI machines or those that are contemplating them in the future to rely on the 1,500-2,200 liters of helium necessary to maintain the functionality of a standard MRI.
The increasing awareness of small animal research is playing a pivotal role in fuelling the growth of the small animal imaging market on multiple fronts. Firstly, as more stakeholders become cognizant of the indispensable role that small animal models play in preclinical research, there is a heightened demand for advanced imaging technologies that can facilitate more precise and comprehensive studies in these models. For instance, UNC School of Medicine (US) advocate for diverse collaborations among different entities to explore emerging imaging techniques, innovative contrast agents, and novel applications across various research domains, especially for preclinical research studies.
Furthermore, researchers recognize the value of small animal imaging in elucidating disease mechanisms, evaluating therapeutic interventions, and predicting clinical outcomes, thereby driving the adoption of innovative imaging modalities. Additionally, heightened awareness among funding agencies, policymakers, and regulatory bodies regarding the importance of supporting small animal research is resulting in increased investment and favorable regulatory environments, further propelling market growth.
The Small Animal Imaging Market segmentation, based on Product, includes Imaging modality and reagent. Imaging modality is further segmented into optical imaging and nuclear imaging. Imaging studies bifurcated into computed tomography (CT), magnetic resonance imaging (MRI), ultrasonography. Further, optical Imaging is segmented into Photoacoustic Tomography and Optical Coherence Tomography, and Nuclear Imaging is further segmented into Micro PET System, Micro SPECT System, Micro MRI System, Micro CT System, and Others.
The imaging modality segment held the majority share in 2022 in the Small Animal Imaging Market revenue. This is attributed to the optical imaging techniques, such as bioluminescence and fluorescence imaging, provide high spatial resolution, enabling researchers to visualize molecular and cellular events at the tissue and subcellular levels in small animal models and nuclear imaging techniques offer high sensitivity, allowing for the detection of low concentrations of radiotracers within tissue.
SMALL ANIMAL IMAGING MARKET SIZE, BY PRODUCT, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The Small Animal Imaging Market segmentation is based on application that includes, monitoring drug treatment programme, bio distribution studies, cancer cell detection, biomarkers, longitudinal studies. The bio distribution studies segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the increasing collaboration among researchers, veterinarians, imaging technologists and the drug administration and imaging procedures.
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North America small animal imaging market accounted for the largest market share in 2022. This is due to the growing research and development activities in the field of pharmaceuticals and biotechnology and rising prevalence of chronic diseases in pets in the North American region. Companies such as Bruker (US), Analytik Jena GmbH+Co. KG (Germany), Aspect Imaging Ltd (US), and MR Solutions (UK) are actively working on improving small animal imaging and fulfilling the demands of customers.
Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: SMALL ANIMAL IMAGING MARKET SIZE, BY REGION 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR database, and analyst review
Europe small animal imaging market accounts for the second-largest market share due to growing demand for preclinical imaging in the pharmaceutical and biotechnology industry, increasing government funding for research and development in the field of molecular imaging and Strong presence of leading imaging equipment manufacturers in the region the region. further, Germany small animal imaging market was attributed to hold the largest market share, and the France small animal imaging market is expected to fastest-growing market in the European region.
The Asia-Pacific small animal imaging market is expected to grow at a significant share from 2023 to 2032. This is due to the growing demand for preclinical research in drug discovery and development, increasing healthcare expenditure, and technological advancements in imaging modalities such as MRI, CT, PET, and SPECT in the region. Moreover, China small animal imaging market is expected to hold the largest market share, and Japan small animal imaging market is expected fastest-growing market in the Asia-Pacific region.
The Rest of the World is segmented into the Middle East, Africa, and Latin America. The small animal imaging market in the above-mentioned regions is likely to witness growth due to Increasing investment in research and development in the healthcare sector, and the rising healthcare expenditure in the Middle East region Moreover, political instability and security concerns impacting healthcare infrastructure development is affecting the market's growth to some extent in these regions.
Small Animal Imaging Key Market Players & Competitive Insights
The Small Animal Imaging Market is characterized by the presence of many global, regional, and local vendors. Developments in the healthcare industry and growing research and development make the small animal imaging market lucrative. To expand their reach and optimize their operational costs, the major players focus on obtaining regulatory authorizations from government agencies for their products and emphasize acquisitions and product launches to gain a substantial market share. The market comprises tier-1, tier-2, and local players.
The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such Bruker (US), Analytik Jena GmbH+Co. KG (Germany), Aspect Imaging Ltd (US), and MR Solutions (UK) dominate the Small Animal Imaging Market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.
One of the primary business strategies adopted by manufacturers in the global small animal imaging industry to benefit clients and expand the small animal imaging market sector is to manufacture locally to reduce operating costs.
MR Solutions manufactures and distributes the first line of commercial superconducting, cryogen-free (dry magnet) preclinical magnetic resonance imaging systems in the world. Modules for SPECT, PET, and CT are sold by the company. Furthermore, MR Solutions provides consulting services on the design and development of innovations in the field of MRI scanning to MRI scanner manufacturers, academic institutions, and specialized laboratories worldwide.
With a team of seasoned professionals and an in-depth understanding of magnetic resonance imaging, MR Solutions can consistently develop and enhance its offerings. The company's overseas operations are situated in the United States and Australia. Furthermore, the company is growing its clientele internationally and boasts installations in over 40 countries.
Also, Bruker (US) develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions worldwide. The company operates through two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear and explosive detection in emergency response, homeland security, and defense applications; and analytical and process analysis instruments and solutions.
The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments, and spark optical emission spectroscopy systems. Furthermore, the company has operations in the Americas, Asia-Pacific, and the Middle East.
Key Companies in the Small Animal Imaging Market include
Small Animal Imaging Industry Developments
October 2019: MR Solutions unveiled their state-of-the-art PET/CT preclinical imaging systems at EANM '19, the European Association of Nuclear Medicine, in Barcelona. The product’s four-model range can accommodate small animals up to 12 kg in weight, and it includes a small benchtop PET/CT.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)